Rising numbers of people are needing hospital treatment for side effects from weight loss injections and it may be affecting ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Analyst Jeff Johnson from Robert W. Baird maintained a Buy rating on Insulet (PODD – Research Report) and keeping the price target at ...

Mike Kratky has given his Buy rating due to a combination of factors ... The firm engages in the development, manufacture and marketing of an insulin infusion system for people with insulin-dependent ...

Shares of MannKind Co. (NASDAQ:MNKD – Get Free Report) have received a consensus recommendation of “Buy” from the seven ...

They set a “buy” rating and a $57.00 price target for the company ... The company's flagship product is the t:slim X2 insulin ...

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." ...

Managing stress and maintaining overall health can be quite challenging in today’s fast-paced world. Many people turn to ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

The company recently got expanded insurance coverage in France and released an over-the-counter CGM option in the U.S., ...